Poseida Therapeutics

Yahoo Finance • last year

Poseida Therapeutics to Present at Two Upcoming Investor Conferences

SAN DIEGO, Nov. 7, 2023 /PRNewswire/ -- Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage cell and gene therapy company advancing a new class of treatments for patients with cancer and rare diseases, today announced that the Comp... Full story

Yahoo Finance • 2 years ago

Poseida Therapeutics Announces Proposed Public Offering of Common Stock

SAN DIEGO, Aug. 4, 2022 /PRNewswire/ -- Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage biopharmaceutical company utilizing proprietary genetic engineering platform technologies to create cell and gene therapeutics with the cap... Full story